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1. Introduction now provide evidence that the dephosphorylation of 
inhibitor-l is controlled by the deinhibitor protein. 
Mammalian tissues contain an inactive multisub- 
strate [ 1,2] protein phosphatase which can be acti- 
vated by another protein factor in the presence of 
ATP and Mg2+ [3-61. The activating factor (FA) is a 
bifunctional protein, also displaying synthase kinase 
activity independent of cyclic AMP and Ca” [6,7]. 
Activation of the catalytic subunit (Fc) of this 
ATP,Mg2+-dependent phosphatase by the activating 
protein factor (FA) is mediated by another subunit of 
this phosphatase: the modulator protein [8], previ- 
ously termed inhibitor-2. The activated F, is indis- 
tinguishable from ‘the multifunctional phosphatase-1’ 
[ 1,8]. The spontaneously active glycogen-bound 
phosphatase isolated from dog liver [9] as well as the 
spontaneously active multisubstrate protein phos- 
phatase from skeletal muscle [2] can be converted to 
the ATP,Mg’+-dependent enzyme form, the former 
after incubation with the modulator protein [IO]; the 
latter inactivates spontaneously because of the pres- 
ence of the same modulator protein [2]. 
2. Materials and methods 
The heat-stable phosphatase inhibitor-l [ 1 l] 
which is only active after phosphorylation by protein 
kinase, has been identified in a variety of tissues 
[ 12,131 and the implication of inhibitor-l in hor- 
monal regulation has been demonstrated [14-171. 
The inhibition of the protein phosphatase by inhibi- 
tor-l as well as by the protein phosphatase modulator 
(inhibitor-2) can be neutralized by a deinhibitor pro- 
tein associated with the glycogen-bound phosphatase 
of liver [ 181. To date the in vitro dephosphorylation 
of inhibitor-l only occurs in the presence of non- 
physiological concentrations of Mn2+ [ 11 ,13,19]. We 
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Materials and methods were essentially as in [S]. 
Phosphatase activity is expressed as nmol [32P] phos- 
phate released/min in the 30 ~1 assay at 30°C with 
labeled phosphorylase (1 mg/ml - 10 PM) or inhibi- 
tor-l (0.02 mg/ml - 1 PM) as substrate. The deinhibi- 
tor protein was isolated from the glycogen pellet of 
dog liver, and extensively purified (J. G., T. C., W. M., 
in preparation). Skeletal muscle inhibitor-l was either 
kindly provided by Dr P. Cohen (University of 
Dundee) or prepared according to [20]. [32P]Inhibi- 
tor-1 (5-6 X 10’ cpm/nmol), with an incorporation 
of phosphate close to 1 mol/mol, was prepared by 
using [T-~‘P] ATP and the catalytic unit of protein 
kinase [22]; after boiling, the phosphorylated form of 
inhibitor-l was reisolated by Sephadex G-50 gel fil- 
tration. The deinhibitor was assayed by its ability to 
relieve the inhibition of the ATP,Mg2+-dependent 
phosphatase by the phosphatase modulator in the fol- 
lowing assay: 10 ~1 containing 10 mU F,, a saturat- 
ing amount of F,, 2 mM MgC12, 0.4 mM ATP, an 
amount of phosphatase modulator which inhibits this 
10 mU by SO%, 20 mM Tris-HCl (pH 7.4) 0.5 mM 
dithiothreitol and 1 mg bovine serum albumin/ml was 
preincubated with 10 ~1 deinhibitor sample, MnC12 or 
buffer for 15 min at 30°C. The dephosphorylation 
was started by adding 10 ~1 labeled phosphorylase a 
(3 mg/ml). After 10 min the reaction was stopped by 
20% trichloroacetic acid and the soluble 32P counted 
as in [5]. A plot of percentage activity against dein- 
hibitor concentration was linear up to 75% deinhibi- 
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tion. In this assay 1 unit of deinhibitor increased the 
phosphatase activity by 1 mu. The liver F, used [4] 
in any of the experiments described is still satu- 
rated with modulator, necessary for its activity [8]. 
Skeletal muscle F, and phosphatase modulator were 
purified according to [6] and [21], respectively. 
3. Results 
Well-fed dogs were killed by shooting and the liver 
homogenized with a low speed overhead type blendor 
(Novamix MT II) in 2.5 vol. buffer containing 20 mM 
Tris-HCl @H 7.8) 0.5 mM dithiothreitol, 1 mM 
EDTA, 1 mM EGTA, 0.25 M sucrose and a cocktail 
of protease inhibitors as in [2]. This and all subse- 
quent steps were carried out at 4°C. After centrifuga- 
tion at 8000 X g for 10 min, the supernatant was fil- 
tered through glass wool and the filtrate centrifuged 
for 60 min at 150 000 X g. The bulk of the microso- 
ma1 and lysosomal fraction was washed off from the 
glycogen pellet, which was then resuspended in a vol- 
ume of buffer A (pH 7.8) (10 mM Tris-HCI, 0.5 mM 
dithiothreitol) equal to 1/3rd of the liver weight and 
adsorbed onto DEAE-52 cellulose (5 X 20 cm col- 
umn), equilibrated in the same buffer. The column 
was washed extensively (+500 ml) with the equilibrat- 
ing buffer until the absorbance at 280 nm was (0.05. 
The phosphatase activity was subsequently eluted 
from the column with 1500 ml of a linear salt gradi- 
ent (O-O.4 M NaCl in the buffer). The breakthrough 
volume contained the glycogen but no phosphatase 
nor deinhibitor activity. The spontaneously active 
phosphorylase phosphatase activity eluted in two 
peaks (fig.1). Most of the deinhibitor activity eluted 
together with the first peak of phosphatase although 
some of the free deinhibitor protein came out just 
in front of the phosphatase. The abrupt decrease in 
deinhibitor activity is only apparent, due to the pres- 
ence of AMP in fractions 11 O-l 30 (up to 1 mM in 
fraction 120). The fractions indicated by the hori- 
zontal bars, were pooled and concentrated by lyophi- 
lization (pool 1) or by precipitation with 60% ammo- 
nium sulphate (pool 2). The lyophilized powder of 
pool 1 was dissolved in 8 ml buffer A (pH 7.4) dia- 
lyzed for 1 h against the same buffer and applied onto 
a Sephadex G-l 50 superfine column (2.5 X 60 cm), 
equilibrated in the same buffer. The deinhibitor now 
perfectly overlapped the phosphatase activity (fig.2) 
except for a small shoulder in the lower-M, range. 
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Fig.1. Separation of the glycogen-bound phosphatase(s) by 
DEAE-cellulose chromatography. The resuspended glycogen 
pellet was chromatographed on a DEAE-cellulose column, 
and fractionated with a linear NaCl gradient (---) as 
described in the text. Phosphorylase phosphatase activity 
(o-o) was measured after a lOO-fold dilution. Deinhibitor 
activity (A-A) was measured on 1: 2 diluted boiled frac- 
tions as described in methods. Fractions (12.5 ml/fraction) 
were pooled as indicated. 
The precipitated proteins of pool 2 were dissolved in 
buffer A (pH 7.4) and dialyzed overnight. Analyzed 
by sucrose gradient centrifugation with [r4C]ovalbu- 
min (45 OOOM,) as an internal marker, the pool 1 
phosphatase showed M, 5 1 000 and the pool 2 
enzyme 45 000 Mr. 
The phosphorylase phosphatase present in a resus- 
pended glycogen pellet, filtered over Sephadex G-25 
(12 000-30 000 U/kg liver) is almost insensitive to 
the phosphatase modulator protein (inhibitor-2) 
(fig.3) and dephosphorylates inhibitor-l quite well 
without added Mn2+ (table 1). The phosphatase activ- 
ity in pool 1 of the DEAF-cellulose eluate behaves 
similarly, whereas the pool 2 enzyme is very sensitive 
to inhibition by inhibitor-l and inactivation to F, by 
the phosphatase modulator [IO] (fig.3) and is virtu- 
ally unable to dephosphorylate inhibitor-l in the 
absence of Mn2+. However, preincubation of the 
pool 2 enzyme with the purified deinhibitor protein 
abolished its Mn2+ requirement for the inhibitor-l 
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Fig.2. Gel filtration of the phosphatase deinhibitor complex 
on Sephadex G-150. The lyophilized pool 1 was filtered on a 
Sephadex G-150 column as described in the text. Fractions 
of 2.4 ml were collected. Symbols and assays are as in fig.1. 
dephosphorylation (table 1) and restored its resis- 
tance to inhibition by the heat-stable proteins (fig.3). 
The pool 2 phosphatase constituted 60-90% of the 
total phosphatase activity recovered in the DEAE- 
cellulose step. The data (recalculated for easy com- 
parison) obtained with skeletal muscle phosphatase-1 
[l] are also included in table 1. It is important to 
recollect that phosphatase-1 was stored in 6 mM Mn*+ 
and diluted in EGTA before the assay. The K, for 
Fig.3. Effect of the phosphatase modulator on the activity of 
the glycogen-bound phosphatases. Different concentrations 
of the phosphatase modulator were included in the 20 ~1 
preincubation mixture with 7 mU of the resuspended and 
desalted (Sephadex G-25) glycogen pellet (T-O), with 
12 mU deinhibitor-free phosphatase (m--m) or with 17 mU 
reconstituted enzyme (deinhibitor free phosphatase preincu- 
bated with a saturating concentration of deinhibitor protein 
in buffer A (pH 7.4) during 10 min at 30°C) (A-A). The 
100% on the ordinate represents the phosphatase activity 
measured in the absence of modulator. 
Mn’+ in the dephosphorylation of inhibitor-l by the 
deinhibitor-free phosphatase, is 25 /.LM so that resid- 
ual Mn*+ might explain the rather high control values 
obtained with phosphatase-1 in the absence of dein- 
hibitor protein and added Mn’+. 
Table 1 
Stimulation of the dephosphorylation of inhibitor-l by the deinhibitor protein or Mn’+ 
Protein phosphatase Phosphorylase 
phosphatase 
(mu/ml) 
Inhibitor-l phosphatase (mu/ml) 
Control + Deinhibitor + Mn*+ (0.25 mM) 
Total glycogen pellet 
Deinhibitor phosphatase 
complex (pool 1) 
Deinhibitor free phos- 
phatase (pool 2) 
Phosphatase-1 
700 49.1 61 14.5 
1000 21.2 52 46.8 
560 2 51 48 
430 9.2 13.7 
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4. Discussion 
The glycogen pellet obtained after high speed cen- 
trifugation of a liver extract of a well-fed dog was 
found to contain >50% of the spontaneously active 
phosphorylase phosphatase of the original extract. 
DEAE-cellulose chromatography of this fraction 
revealed 2 peaks of phosphorylase phosphatase activ- 
ity. One form, to which the deinhibitor protein is 
associated, has Mr 5 1 000 while the other form in 
which no deinhibitor protein could be detected, dis- 
plays Mr 45 000. 
The dephosphorylation of inhibitor-l has always 
been problematic since it was only observed in the 
presence of unphysiological concentrations of Mn2+ 
[ 11 ,13,19]. The discovery of the deinhibitor protein 
in the glycogen pellet [ 181 could be considered as a 
partial solution of the problem, since by neutralising 
the effect of inhibitor proteins, the deinhibitor pro- 
tein would protect the phosphatase during glycogen 
accumulation. This observation that the spontane- 
ously active phosphatase to which the deinhibitor is 
associated can also dephosphorylate inhibitor-l not 
only makes the requirement of Mn2+ unnecessary, but 
completes the physiological phosphorylation- 
dephosphorylation cycle for inhibitor-l. 
The deinhibitor-free phosphatase, obtained in the 
pool 2 of the DEAE-cellulose chromatography is 
unable to dephosphorylate inhibitor-l and very sen- 
sitive to its inhibition and to inactivation by the 
modulator protein. When preincubated with the 
deinhibitor protein the phosphatase again becomes 
capable of dephosphorylating inhibitor-l, and - pro- 
tected by the protein deinhibitor - the phosphatase 
does not interconvert to its inactive F,-form by the 
action of the modulator. 
The physiological significance of the protein phos- 
phatase inhibition by inhibitor-l and the phosphatase 
modulator (inhibitor-2) has been questioned [23,24] 
since it has been proposed that the inhibitor protein 
is not active before heating and that the sensitivity of 
the phosphatase to the inhibition is rather an index of 
prior proteolysis. These and earlier [ 181 observations 
show that the association of the deinhibitor with the 
phosphatase not only protects the phosphatase from 
inhibition but also controls the dephosphorylation of 
inhibitor-l. Since the deinhibitor protein is trypsin- 
and pronase-labile [ 181 proteolysis can indeed 
explain an increased sensitivity to the inhibitor pro- 
teins. However, this does not rule out the existence of 
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protein phosphatases insensitive to the inhibitor pro- 
teins, such as the high-M* cytosolic phosphatase from 
dog liver [ 131, or the phosphatase specific for the 
dephosphorylation of the a-subunit of phosphoryla- 
ase b kinase [25]. Heat treatment is not necessary for 
the conversion of a ‘precursor’ to its inhibitory [23] 
form since not only the inhibitor-l-mediated cyclic 
AMP effect on the phosphatase was observed on 
unboiled preparations [26-281, but Nimmo and 
Cohen [ 191 purified inhibitor-l without any boiling 
step. In our laboratory, inhibitor-2 (now called the 
phosphatase modulator) was originally discovered 
in unboiled preparations of adrenal cortex during 
ordinary DEAE-cellulose chromatography [29] and 
modulator activity can be measured in unboiled 
preparations of ATP,Mg”-dependent phosphatase 
(Vandenheede, Yang and W. M., unpublished). 
In vivo experiments have shown that the degree of 
phosphorylation of inhibitor-l increased in response 
to epinephrine in skeletal muscle [ 14,15,17]. A 
reverse effect by insulin [ 161 has been described, but 
this observation seems controversial [ 171. A decrease 
in inhibitor-l activity could be explained by a 
decreased cyclic AMP-dependent protein kinase activ- 
ity, but also by an increased protein phosphatase 
activity, which would explain many of the actions of 
insulin on intermediary metabolism. The deinhibitor 
protein neutralizes the effect of the inhibitor proteins 
and could be responsible for the dephosphorylation 
of inhibitor-l, while at the same time it prevents the 
conversion to the inactive F, by the phosphatase 
modulator, thus keeping the phosphatase in the active 
state. In this way, the deinhibitor protein could play 
a key role in the metabolic regulation of protein 
phosphatase activity. 
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